An innovative laboratory culture system has succeeded, for the first time, in reproducing the full course of events underlying the development of Alzheimer's disease. Using the system they developed, investigators from the ...
Oct 12, 2014
1
0
Researchers at the RIKEN Brain Science Institute (BSI) and their collaborators have shed light on the function of a little-studied amyloid peptide in promoting Alzheimer's disease (AD). Their surprising findings reveal that ...
Jul 3, 2011
0
0
Several years ago, MIT neuroscientists showed that they could dramatically reduce the amyloid plaques seen Alzheimer's disease in mice simply by exposing the animals to light flickering at a specific frequency.
May 7, 2019
0
384
A team of neuroscientists has identified a potential means to address the loss of cognitive function due to Alzheimer's disease by targeting protein synthesis in mice. Their findings, reported in the journal Science Signaling, ...
Feb 2, 2021
8
402
A substance known as amyloid beta protein gets a lot of attention from scientists. Beta amyloid, as it's also called, is a normal brain protein found in everyone, but for an unknown reason it gunks up in the brains of patients ...
Jun 11, 2019
0
130
Neuroscientists at the University of Southampton have made a significant development in understanding how Alzheimer's disease spreads through the brain, discovering a significant period of time where medical intervention ...
Oct 29, 2019
0
19
Researchers in UC Santa Barbara neuroscientist Kenneth S. Kosik's lab have discovered a novel organelle—a previously unknown cell structure whose function it is to help clean up faulty proteins in times of stress and keep ...
Jun 14, 2022
0
145
Massachusetts General Hospital (MGH) investigators have discovered a mechanism behind the spread of neurofibrillary tangles - one of the two hallmarks of Alzheimer's disease - through the brains of affected individuals. In ...
Oct 26, 2015
0
123
Partner companies Eisai and Biogen recently announced promising clinical trial results for their new Alzheimer's drug lecanemab. Over 18 months, patients treated with lecanemab experienced slower symptom progression than ...
Oct 14, 2022
0
5
Scientists from the world-leading Sheffield Institute for Translational Neuroscience (SITraN) have discovered a novel pathway contributing to dementia in individuals that lack the typical signs of Alzheimer's disease in the ...
Jun 29, 2015
0
72
